139 related articles for article (PubMed ID: 33536950)
1. Characteristics of the Optimal Cognitive Behavioral Analysis System of Psychotherapy (CBASP) Therapist Role.
McCullough JP
Front Psychiatry; 2020; 11():609954. PubMed ID: 33536950
[TBL] [Abstract][Full Text] [Related]
2. [Psychotherapy of chronic depression: contributions of CBASP by McCullough].
Kramer U; Belz M; Caspar F
Encephale; 2013 Apr; 39(2):137-42. PubMed ID: 23107463
[TBL] [Abstract][Full Text] [Related]
3. Review of Treating chronic depression with disciplined personal involvement: Cognitive behavioral analysis system of psychotherapy (CBASP).
Hellerstein DJ
Psychotherapy (Chic); 2008 Sep; 45(3):416-7. PubMed ID: 22122501
[TBL] [Abstract][Full Text] [Related]
4. Group Cognitive Behavioral Analysis System of Psychotherapy (CBASP): A Pilot Study for Bipolar Depression.
Sayegh L; Touré EH; Farquhar E; Beaulieu S; Renaud S; Rej S; Perreault M
Front Psychiatry; 2020; 11():565681. PubMed ID: 33173513
[TBL] [Abstract][Full Text] [Related]
5. Impact of Baseline Characteristics on the Effectiveness of Disorder-Specific Cognitive Behavioral Analysis System of Psychotherapy (CBASP) and Supportive Psychotherapy in Outpatient Treatment for Persistent Depressive Disorder.
Serbanescu I; Backenstrass M; Drost S; Weber B; Walter H; Klein JP; Zobel I; Hautzinger M; Meister R; Härter M; Schramm E; Schoepf D
Front Psychiatry; 2020; 11():607300. PubMed ID: 33408656
[No Abstract] [Full Text] [Related]
6. Cognitive Behavioral Analysis System of Psychotherapy as group psychotherapy for chronically depressed inpatients: a naturalistic multicenter feasibility trial.
Sabaß L; Padberg F; Normann C; Engel V; Konrad C; Helmle K; Jobst A; Worlitz A; Brakemeier EL
Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):783-796. PubMed ID: 28956140
[TBL] [Abstract][Full Text] [Related]
7. Two-Year Follow-Up after Treatment with the Cognitive Behavioral Analysis System of Psychotherapy versus Supportive Psychotherapy for Early-Onset Chronic Depression.
Schramm E; Kriston L; Elsaesser M; Fangmeier T; Meister R; Bausch P; Zobel I; Bailer J; Wambach K; Backenstrass M; Klein JP; Schoepf D; Schnell K; Gumz A; Löwe B; Walter H; Wolf M; Domschke K; Berger M; Hautzinger M; Härter M
Psychother Psychosom; 2019; 88(3):154-164. PubMed ID: 31121581
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the impact and acceptability of Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for chronic depression.
Linstead J; Doyle M
Behav Cogn Psychother; 2022 Nov; 50(6):644-648. PubMed ID: 35730130
[TBL] [Abstract][Full Text] [Related]
9. Interpersonal Change During Inpatient CBASP Treatment: Focus on Group Therapy.
Guhn A; Schön D; Zische Y; Sterzer P; Köhler S
Front Psychiatry; 2021; 12():620037. PubMed ID: 33716820
[No Abstract] [Full Text] [Related]
10. Investigating the feasibility and effectiveness of a modular treatment program for children and adolescents with depression and interpersonal problems: study protocol of a quasi-experimental pilot feasibility trial (CBASP@YoungAge).
Dippel N; In-Albon T; Schneider S; Christiansen H; Brakemeier EL
Pilot Feasibility Stud; 2022 Jul; 8(1):145. PubMed ID: 35821072
[TBL] [Abstract][Full Text] [Related]
11. Group Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for persistently depressed outpatients: a retrospective chart review.
Potijk MR; Aan Het Rot M; Parlevliet FM; Schoevers RA; Eldering MJ
Br J Clin Psychol; 2020 Nov; 59(4):552-564. PubMed ID: 32920864
[TBL] [Abstract][Full Text] [Related]
12. Treatment of chronically depressed patients: a multisite randomized controlled trial testing the effectiveness of 'Cognitive Behavioral Analysis System of Psychotherapy' (CBASP) for chronic depressions versus usual secondary care.
Wiersma JE; van Schaik DJ; van Oppen P; McCullough JP; Schoevers RA; Dekker JJ; Blom MB; Maas K; Smit JH; Penninx BW; Beekman AT
BMC Psychiatry; 2008 Mar; 8():18. PubMed ID: 18366729
[TBL] [Abstract][Full Text] [Related]
13. Cognitive-Behavioural Analysis System of Psychotherapy (CBASP), a drug, or their combination: differential therapeutics for persistent depressive disorder: a study protocol of an individual participant data network meta-analysis.
Furukawa TA; Schramm E; Weitz ES; Salanti G; Efthimiou O; Michalak J; Watanabe N; Cipriani A; Keller MB; Kocsis JH; Klein DN; Cuijpers P
BMJ Open; 2016 May; 6(5):e011769. PubMed ID: 27147393
[TBL] [Abstract][Full Text] [Related]
14. The treatment of chronic depression with cognitive behavioral analysis system of psychotherapy: a systematic review and meta-analysis of randomized-controlled clinical trials.
Negt P; Brakemeier EL; Michalak J; Winter L; Bleich S; Kahl KG
Brain Behav; 2016 Aug; 6(8):e00486. PubMed ID: 27247856
[TBL] [Abstract][Full Text] [Related]
15. Patients' interpersonal problems as moderators of depression outcomes in a randomized controlled trial comparing mindfulness-based cognitive therapy and a group version of the cognitive-behavioral analysis system of psychotherapy in chronic depression.
Probst T; Schramm E; Heidenreich T; Klein JP; Michalak J
J Clin Psychol; 2020 Jul; 76(7):1241-1254. PubMed ID: 31997369
[TBL] [Abstract][Full Text] [Related]
16. The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: A secondary analysis.
Bausch P; Fangmeier T; Zobel I; Schoepf D; Drost S; Schnell K; Walter H; Berger M; Normann C; Schramm E
Clin Psychol Psychother; 2017 Sep; 24(5):1155-1162. PubMed ID: 28326653
[TBL] [Abstract][Full Text] [Related]
17. Impaired empathic functioning in chronic depression: Behavioral evidence for the Cognitive Behavioral Analysis System of Psychotherapy (CBASP) model.
Guhn A; Merkel L; Heim C; Klawitter H; Teich P; Betzler F; Sterzer P; Köhler S
J Psychiatr Res; 2022 Aug; 152():79-85. PubMed ID: 35716512
[TBL] [Abstract][Full Text] [Related]
18. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Schatzberg AF; Rush AJ; Arnow BA; Banks PL; Blalock JA; Borian FE; Howland R; Klein DN; Kocsis JH; Kornstein SG; Manber R; Markowitz JC; Miller I; Ninan PT; Rothbaum BO; Thase ME; Trivedi MH; Keller MB
Arch Gen Psychiatry; 2005 May; 62(5):513-20. PubMed ID: 15867104
[TBL] [Abstract][Full Text] [Related]
19. Negative Effects of a Multimodal Inpatient CBASP Program: Rate of Occurrence and Their Impact on Treatment Outcome in Chronic and Treatment-Resistant Depression.
Herzog P; Häusler S; Normann C; Brakemeier EL
Front Psychiatry; 2021; 12():575837. PubMed ID: 34434122
[No Abstract] [Full Text] [Related]
20. Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for chronic depression: clinical characteristics and six month clinical outcomes in an open case series.
Swan JS; Macvicar R; Christmas D; Durham R; Rauchhaus P; McCullough JP; Matthews K
J Affect Disord; 2014 Jan; 152-154():268-76. PubMed ID: 24182417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
